These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 19615811

  • 1. Warnings against candesartan in pregnancy are not implemented in physicians' practice.
    Borthen C, Oglaend B, Eggebøe T, Ellingsen CL, Schjøtt J.
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):235. PubMed ID: 19615811
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Importance of a fixed combination of AT1-receptor blockade and hydrochlorothiazide for blood pressure lowering in cardiac risk patients. A postmarketing surveillance study with candesartan/HCTZ].
    Bramlage P, Schönrock E, Odoj P, Wolf WP, Funken C.
    MMW Fortschr Med; 2008 Feb 07; 150(6):40. PubMed ID: 18323344
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The X-cellent Study.
    Safar ME.
    Am J Hypertens; 2006 Jan 07; 19(1):8-9. PubMed ID: 16461182
    [No Abstract] [Full Text] [Related]

  • 7. Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex).
    Ogihara T, Ueshima K, Nakao K, Fukiyama K, Oba K, Yasuno S, Fujimoto A, Sato T, Matsuoka H, Saruta T, CASE-J Ex Study Group.
    Hypertens Res; 2011 Dec 07; 34(12):1295-301. PubMed ID: 21833000
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Course and outcome of pregnancy after maternal exposure to angiotensin-II-receptor blockers--case report and review of the literature.
    Enzensberger C, Eskef K, Schwarze A, Faas D, Axt-Fliedner R.
    Ultraschall Med; 2012 Oct 07; 33(5):493-6. PubMed ID: 21630188
    [No Abstract] [Full Text] [Related]

  • 10. Lowering blood pressure in acute stroke: the SCAST trial.
    Hankey GJ.
    Lancet; 2011 Feb 26; 377(9767):696-8. PubMed ID: 21316753
    [No Abstract] [Full Text] [Related]

  • 11. [AT-1 blockers are different in their effects. The forgetful patients begin to notice it especially].
    MMW Fortschr Med; 2003 Apr 10; 145(15):62. PubMed ID: 15104271
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Candesartan versus imidapril in hypertension: a randomised study to assess effects of anti-AT1 receptor autoantibodies.
    Wei F, Jia XJ, Yu SQ, Gu Y, Wang L, Guo XM, Wang M, Zhu F, Cheng X, Wei YM, Zhou ZH, Fu M, Liao YH, SOT-AT1 Study Group.
    Heart; 2011 Mar 10; 97(6):479-84. PubMed ID: 21296780
    [Abstract] [Full Text] [Related]

  • 17. [CHARM].
    Momomura S.
    Nihon Rinsho; 2006 Aug 10; 64 Suppl 6():431-6. PubMed ID: 16981575
    [No Abstract] [Full Text] [Related]

  • 18. [Importance of a fixed combination of AT1-receptor blockade and hydrochlorothiazide for blood pressure lowering in cardiac risk patients. A postmarketing surveillance study with Candesartan/HCTZ].
    Bramlage P, Schönrock E, Odoj P, Wolf WP, Funken C.
    MMW Fortschr Med; 2008 Jan 17; 149 Suppl 4():172-81. PubMed ID: 18402243
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Fetal toxicity of angiotensin-II receptor antagonists].
    Payen V, Chemin A, Jonville-Béra AP, Saliba E, Cantagrel S.
    J Gynecol Obstet Biol Reprod (Paris); 2006 Nov 17; 35(7):729-31. PubMed ID: 17088776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.